A clinical study to provide idelalisib to subjects previously treated with GS-9820

Update Il y a 4 ans
Reference: EUCTR2015-005766-39

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

The primary objective of this study is to provide idelalisib to subjects receiving GS-9820 in Study GS-US-315-0102 at the time of study closure.


Inclusion criteria

  • Lymphoid Malignancies

Links